Last week, my colleague reported on a new Stanford study showing that free drug samples lead to more expensive prescriptions. Over the weekend, dermatologist Al Lane, MD, senior author of the study, appeared on PBS NewsHour to discuss the implications of his findings. (He's also quoted in a New York Times blog post on the research.) After mentioning that pharmaceutical companies spend more than $6 billion a year on sampling, he told NewsHour's Hari Sreenivasan "that [this] cost eventually has to be paid by someone." And he closes on a powerful note:
One of the focuses of our study was for the dermatologists to realize that although they think they’re helping the patients, they're really being manipulated to write for more expensive medications with no proven benefit of those medications over the generic drugs.
Previously: Drug samples lead to more expensive prescriptions, Stanford study finds